Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Listen to this Section


$13.43
-0.5300 ( -3.80% ) 746.8K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Insider Ownership Transactions

Total Amount Purchased: -870,196.00 | $ -11,686,732.28

Date Type Amount Purchased Purchaser
2024-07-19 Sale -34500.00 Austin Mark John
2024-06-24 Sale -100000.00 Hunt Jonathan Robert
2024-06-24 Sale -500000.00 Spoor Johan M.
2024-06-24 Sale -23000.00 Williamson Robert F III
2024-06-24 Sale -23000.00 Morich Frank
2024-06-24 Sale -23000.00 Woods Lori A
2024-06-24 Sale -23000.00 HENSON HEIDI
2024-06-24 Sale -150000.00 Puhlmann Markus
2024-06-18 Buy 4504.00 Woods Lori A
2024-06-18 Buy 1800.00 Hunt Jonathan Robert

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 80 Aug 13, 2024
8-k 8K-related 14 Aug 13, 2024
8-k 8K-related 123 Aug 13, 2024
8-k/a 8K-related 13 Aug 12, 2024
8-k 8K-related 13 Aug 12, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jun 24, 2024
4 Insider transactions 1 Jun 24, 2024
4 Insider transactions 1 Jun 24, 2024
4 Insider transactions 1 Jun 24, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.